BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 9 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in BioCardia, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +3 vs. Q1 2026
- Shares held
- 1.33M
- +646.8K (+94.2%) vs. Q1 2026
- Total value
- $1.65M
- +$815.9K (+98.2%) vs. Q1 2026
- New holders
- 8
- 4 more added
- Sold out
- 5
- 3 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $1.65M |
| Q1 2026 | 18 | $831.1K |
| Q4 2025 | 20 | $812.3K |
| Q3 2025 | 18 | $551.9K |
| Q2 2025 | 16 | $593.2K |
| Q1 2025 | 12 | $623.8K |
| Q4 2024 | 13 | $272.2K |
| Q3 2024 | 9 | $316.6K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 22 | $790.8K |
| Q4 2023 | 24 | $1.37M |
| Q3 2023 | 16 | $709.6K |
| Q2 2023 | 23 | $4.43M |
| Q1 2023 | 23 | $4.09M |
| Q4 2022 | 25 | $4.87M |
| Q3 2022 | 23 | $3.17M |
| Q2 2022 | 26 | $3.10M |
| Q1 2022 | 24 | $5.49M |
| Q4 2021 | 23 | $5.78M |
| Q3 2021 | 22 | $9.01M |
| Q2 2021 | 20 | $12.3M |
| Q1 2021 | 19 | $13.5M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding BioCardia, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 397,594 | $493.0K | 0.00% | +397,594 | New |
| CM Management, LLC | 300,000 | $372.0K | 0.24% | +170,000+130.8% | Added |
| Vanguard Capital Management LLC | 124,591 | $154.5K | 0.00% | 00.0% | Unchanged |
| Pingora Partners LLC | 120,382 | $149.3K | 0.09% | +84,643+236.8% | Added |
| UBS Group AG | 77,619 | $96.2K | 0.00% | +77,619 | New |
| Geode Capital Management, LLC | 66,664 | $82.7K | 0.00% | −27,623−29.3% | Reduced |
| Vanguard Fiduciary Trust Co | 66,270 | $82.2K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 38,809 | $48.1K | 0.00% | −180.0% | Reduced |
| Brown Advisory Inc | 35,538 | $44.1K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 23,383 | $29.0K | 0.00% | +5,100+27.9% | Added |
| Citadel Advisors LLC | 22,956 | $28.5K | 0.00% | −40,428−63.8% | Reduced |
| StoneX Group Inc. | 20,020 | $24.8K | 0.00% | +20,020 | New |
| Wealth Enhancement Advisory Services, LLC | 18,500 | $16.9K | 0.00% | +18,500 | New |
| Gsa Capital Partners LLP | 12,862 | $16.0K | 0.00% | +12,862 | New |
| Tower Research Capital LLC (TRC) | 3,187 | $3.95K | 0.00% | +209+7.0% | Added |
| Morgan Stanley | 3,105 | $3.85K | 0.00% | 00.0% | Unchanged |
| Allied Private Wealth LLC | 1,449 | $1.40K | 0.00% | +1,449 | New |
| Global Retirement Partners, LLC | 411 | $510 | 0.00% | +411 | New |
| SBI Securities Co., Ltd. | 9 | $11 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 1 | $1 | 0.00% | +1 | New |
| XTX Topco Ltd | 0 | $0 | 0.00% | −24,270−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,355−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −14,780−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −13,900−100.0% | Sold out |
| Vanguard Global Advisers, LLC | 0 | $0 | 0.00% | −268−100.0% | Sold out |